Reduce tremor using brain stimulation
- Trial ID
- NCT05752656
- Official Title
- Short- and Long-term Behavioral, Cognitive and Motor Outcomes of Frameless Deep Brain Stimulation in Patients With Parkinson's Disease: a Prospective Observational Study
- Goal
- Reduce tremor using brain stimulation
- Status
- RECRUITING
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Study Type
- OBSERVATIONAL
- Enrollment
- 100 participants
- Conditions
- Parkinson Disease
- Interventions
- Clinical examinations
Plain-Language Summary
The goal is to track short- and long-term motor, cognitive, and behavioral effects after frameless deep brain stimulation in people with Parkinson's. Frameless DBS uses image-guided, frame-free surgery to place electrodes that deliver continuous electrical pulses to deep brain targets, which can reduce tremor, stiffness, and slowness and may allow lowering levodopa doses while sometimes affecting mood or thinking; researchers will follow patients with regular clinical examinations to see how these areas change over time. The study is enrolling adults 18 and older with idiopathic Parkinson's who are already judged suitable for DBS under standard CAPSIT-PD criteria, excluding only those unable to give informed consent.
Locations
- Flavia Torlizzi, Rome, Italy
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Clinical examinations. The goal is to track short- and long-term motor, cognitive, and behavioral effects after frameless deep brain stimulation in people with Parkinson's. Frameless DBS uses image-guided, frame-free surgery to place electrodes that deliver continuous electrical pulses to deep brain targets, which can reduce tremor, stiffness, and slowness and may allow lowering levodopa doses while sometimes affecting mood or thinking; researchers will follow patients with regular clinical examinations to see how these areas change over time. The study is enrolling adults 18 and older with idiopathic Parkinson's who are already judged suitable for DBS under standard CAPSIT-PD criteria, excluding only those unable to give informed consent.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 11 months.